Yuxuan Che

412 total citations
26 papers, 151 citations indexed

About

Yuxuan Che is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yuxuan Che has authored 26 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Yuxuan Che's work include CAR-T cell therapy research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Yuxuan Che is often cited by papers focused on CAR-T cell therapy research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Yuxuan Che collaborates with scholars based in United States and China. Yuxuan Che's co-authors include Michael Wang, Yang Liu, Yixin Yao, Wei Wang, Qingsong Cai, Preetesh Jain, Jingling Jin, Changying Jiang, Xiuhua Sun and Heng‐Huan Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Yuxuan Che

22 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuxuan Che United States	7	77	59	40	23	17	26	151
Devora Delman United States	6	72 0.9×	91 1.5×	44 1.1×	15 0.7×	23 1.4×	8	188
Suet Ling Felce United Kingdom	7	36 0.5×	83 1.4×	43 1.1×	19 0.8×	14 0.8×	7	135
Bin Meng China	8	38 0.5×	174 2.9×	24 0.6×	31 1.3×	58 3.4×	18	224
Mai Q. Nguyen United States	6	38 0.5×	91 1.5×	20 0.5×	12 0.5×	23 1.4×	6	123
Koramit Suppipat Thailand	8	76 1.0×	169 2.9×	73 1.8×	7 0.3×	21 1.2×	20	250
Li-Ya Chiu Germany	8	84 1.1×	218 3.7×	17 0.4×	16 0.7×	48 2.8×	9	267
Brant Firestone United States	5	79 1.0×	116 2.0×	86 2.1×	12 0.5×	29 1.7×	9	197
Dzana Dervovic Canada	9	112 1.5×	87 1.5×	129 3.2×	5 0.2×	16 0.9×	12	251
Shoukat Afshar‐Sterle Australia	6	87 1.1×	74 1.3×	83 2.1×	23 1.0×	24 1.4×	7	188
Paolo Falvo Italy	8	94 1.2×	81 1.4×	86 2.1×	5 0.2×	31 1.8×	19	198

Countries citing papers authored by Yuxuan Che

Since Specialization

Citations

This map shows the geographic impact of Yuxuan Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxuan Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxuan Che more than expected).

Fields of papers citing papers by Yuxuan Che

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxuan Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxuan Che. The network helps show where Yuxuan Che may publish in the future.

Co-authorship network of co-authors of Yuxuan Che

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxuan Che. A scholar is included among the top collaborators of Yuxuan Che based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxuan Che. Yuxuan Che is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yijing, Changying Jiang, Fangfang Yan, et al.. (2025). BCL-2/BCL-XL dual inhibition triggers Gasdermin D-mediated pyroptosis in mantle cell lymphoma. Cancer Letters. 632. 217961–217961.

Che, Yuxuan, et al.. (2024). Effects of Straw Return Rate on Soil Physicochemical Properties and Yield in Paddy Fields. Agronomy. 14(8). 1668–1668. 7 indexed citations

Che, Yuxuan, Yang Liu, Yixin Yao, et al.. (2023). Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood Cancer Journal. 13(1). 27–27. 13 indexed citations

Che, Yuxuan, Yang Liu, Yijing Li, et al.. (2023). Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma. Blood Advances. 7(14). 3361–3365. 1 indexed citations

Li, Yijing, Heng‐Huan Lee, Changying Jiang, et al.. (2023). Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins. Cell Death and Disease. 14(11). 714–714. 5 indexed citations

Che, Yuxuan, et al.. (2023). Recent advances in CAR T-cell therapy for lymphoma in China. Clinical & Translational Oncology. 25(10). 2793–2800. 3 indexed citations

Che, Yuxuan, et al.. (2023). Advances in the treatment of Hodgkin's lymphoma (Review). International Journal of Oncology. 62(5). 4 indexed citations

Che, Yuxuan, et al.. (2022). Secondary hemophagocytic lymphohistiocytosis triggered by peripheral T‐cell lymphoma: An unusual case report. SHILAP Revista de lepidopterología. 10(11). e6528–e6528. 2 indexed citations

Jiang, Changying, Dapeng Hao, Preetesh Jain, et al.. (2022). TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma. Molecular Cancer. 21(1). 185–185. 53 indexed citations

10.

Li, Lingzhi, Qingsong Cai, Yang Liu, et al.. (2022). Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma. Haematologica. 108(6). 1616–1627. 10 indexed citations

11.

Jiang, Changying, Fangfang Yan, Yuxuan Che, et al.. (2022). Targeting the HSP90-MYC-CDK9 Axis to Overcome Dual Resistance to BTK Inhibition and CAR-T Therapy in Mantle Cell Lymphoma. Blood. 140(Supplement 1). 3512–3513. 2 indexed citations

12.

Jiang, Changying, Dapeng Hao, Preetesh Jain, et al.. (2022). Abstract 771: Multi-omics profiling can predict for relapse and response to brexucabtagene autoleucel CAR T-cell therapy in patients with mantle cell lymphoma. Cancer Research. 82(12_Supplement). 771–771.

13.

Che, Yuxuan, Yang Liu, Heng‐Huan Lee, et al.. (2022). HSP27 Promotes Mantle Cell Lymphoma Growth and Mediates Resistance to Venetoclax. Blood. 140(Supplement 1). 6405–6406. 1 indexed citations

14.

Jin, Jingling, Yijing Li, Yang Liu, et al.. (2021). Bispecific CD19-CD20 and CD19-CD22 CAR-T Cells with Glycogen Synthase Kinase (GSK)-3β Inhibitor TWS119 Treatment Have Superior Therapeutic Effects on Mantle Cell Lymphoma. Blood. 138(Supplement 1). 1698–1698. 3 indexed citations

15.

Liu, Yang, Changying Jiang, Fangfang Yan, et al.. (2021). Pirtobrutinib Overcomes Ibrutinib and Venetoclax Resistance in Mantle Cell Lymphoma. Blood. 138(Supplement 1). 1182–1182. 4 indexed citations

16.

Che, Yuxuan, Yang Liu, Yijing Li, et al.. (2021). Abemaciclib in Combination with Copanlisib to Overcome Therapeutic Resistance in Mantle Cell Lymphoma. Blood. 138(Supplement 1). 2253–2253. 1 indexed citations

17.

Li, Yijing, Yang Liu, Yuxuan Che, et al.. (2021). Combination Therapy of Bcl-2/X L dual Inhibitor AZD0466 with Acalabrutinib to Overcome Therapeutic Resistance in Aggressive R/R Mantle Cell Lymphoma. Blood. 138(Supplement 1). 1867–1867. 1 indexed citations

18.

Liu, Kai‐Li, Yue Yan, Kun Zou, et al.. (2020). Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway. Translational Oncology. 14(1). 100876–100876. 19 indexed citations

19.

Che, Yuxuan, et al.. (2019). Successful treatment of a rare subcutaneous panniculitis‐like T‐cell lymphoma: An unusual case report and literature review. Dermatologic Therapy. 32(3). e12878–e12878.

20.

Che, Yuxuan, et al.. (2016). Critical involvement of the α(1,2)-fucosyltransferase in multidrug resistance of human chronic myeloid leukemia. Oncology Reports. 35(5). 3025–3033. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact